These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7312841)

  • 1. [Preparation of specific anti-hepatitis B immunoglobulin].
    Golosova TV; Margolina AN; Somova AV; Rudnitskaia ME; Tovstyko OI
    Probl Gematol Pereliv Krovi; 1981 Sep; 26(9):60-2. PubMed ID: 7312841
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HBs immunoglobulin].
    Poszwiński P; Kacperska E; Głoskowska-Moraczewska Z; Seyfried H
    Pol Tyg Lek; 1979 Nov; 34(46):1789-91. PubMed ID: 545318
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoglobulins and antibodies in the blood serum of blood donors - HBsAg carriers].
    Chrostowska H; Zółtowska A
    Pol Tyg Lek; 1980 Nov; 35(45):1721-3. PubMed ID: 7220371
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepaga, a new Czechoslovak-made specific anti-HBs immunoglobulin (author's transl)].
    Kselíková M; Petera A; Urbánková J
    Cas Lek Cesk; 1982 Jan; 121(4):105-7. PubMed ID: 7060064
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis markers detected in a Canadian blood donor population.
    Buchner BK; Staszak M; Duravetz J; Moore BP
    Acta Haematol Pol; 1980; 11(2):69-71. PubMed ID: 6252746
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of hepatitis B surface antigen (HBsAg) and antibody (HBsAb) in civilian blood donors in Delhi area.
    Narain S; Gupta ML; Maheshwari HB; Mittal MM
    Indian J Public Health; 1981; 24(3):163-9. PubMed ID: 7251107
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum immunoglobulin level of viral hepatitis patients at different stages of the disease].
    Nagornova TF; Marichev IL; Raksha EA; Markov IS
    Vrach Delo; 1983 Nov; (11):115-6. PubMed ID: 6318447
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conditions for preparation of specific immunoglobulin against B hepatitis (author's transl)].
    Horejsí J; Höglund J; Korínek J; Kselíková M; Malaska Z; Novák J
    Cas Lek Cesk; 1974 Sep; 113(38):1145-50. PubMed ID: 4418924
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of chronic HBsAg carriership in infants of HBsAg-positive mothers by hepatitis B immunoglobulin.
    Reesink HW; Reesink-Brongers EE; Lafeber-Schut BJ; Kalshoven-Benschop J; Brummelhuis HG
    Acta Haematol Pol; 1980; 11(2):79-81. PubMed ID: 7424485
    [No Abstract]   [Full Text] [Related]  

  • 10. Conditions for the preparation of a specific immunoglobulin against hepatitis B.
    Horejsí J; Höglund J; Korínek J; Kselíková M; Malaska Z; Novák J
    Rev Czech Med; 1975; 23(2):49-57. PubMed ID: 1153830
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological markers of viral hepatitis in commercial series of immunoglobulin].
    Burlev VA; Gerasun BA
    Vrach Delo; 1983 Nov; (11):112-4. PubMed ID: 6318446
    [No Abstract]   [Full Text] [Related]  

  • 12. The selection of Danish blood donors according to sex and age in order to secure adequate content of immunoglobulin against hepatitis A and B in pooled plasma.
    Sørensen PG; Tønnesen E; Diederichsen H; Matinussen K
    Dan Med Bull; 1983 Nov; 30(6):421-4. PubMed ID: 6315313
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of HBsAg in Gaza: implications for prevention and control.
    Yassin K; Awad R; Tebi AJ; Queder A; Laaser U
    J Infect; 2002 May; 44(4):252-6. PubMed ID: 12099733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serodiagnostic problems of Non-A, Non-B viral hepatitis].
    Hollós I; László B; Brojnás J; Pohl O; Keszei N; Szalka A; Tolnai G; Sántha M; Schaff Z; Szabados T
    Orv Hetil; 1981 Oct; 122(43):2639-45. PubMed ID: 6798531
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
    Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
    Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positivity rate of hepatitis B surface antigen in 16-year-old first-time blood donors: effectiveness of immunoprophylaxis with hepatitis B vaccine and immunoglobulin in newborn infants with mothers positive for hepatitis B e antigen.
    Uchida S; Tadokoro K
    Jpn J Infect Dis; 2008 Jan; 61(1):94. PubMed ID: 18219148
    [No Abstract]   [Full Text] [Related]  

  • 20. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.